Title

Undue influence of drug firms may find way into diagnoses

Document Type

News Article

Publication Date

10-28-2010

Abstract

Undue industry influence may be compromising the very guidelines that doctors rely on for diagnosing and treating patients. This is because of a legal, but controversial, practice that permits researchers with financial ties to pharmaceutical companies (such as those who participate on company speakers bureaus or who receive large research grants) to serve as experts on medical guideline-writing panels.

Cosgrove, 2010_Boston Globe.pdf (426 kB)
"Undue influence of drug firms may find way into diagnoses," Boston Globe, Letter to the Editor

Publisher

Boston Globe

Additional Files

Cosgrove, 2010_Boston Globe.pdf (426 kB)

Share

COinS